Thyrocare Technologies Limited reported a robust 23% year-on-year revenue growth in Q1FY26. The company's core Pathology segment significantly contributed to this surge.

Thyrocare Technologies Limited (hereinafter referred to as “THYROCARE” NSE: THYROCARE, BSE: 539871), a leading healthcare ...

Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...

Mumbai: After years of relying on external partnerships, Sion hospital is set to expand its efforts to hunt for drug-resistant tuberculosis by adding .

Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new ...

LIC, Lupin, Divi's, 3M India, Abbott India, Fortis Healthcare, Bharti Hexacom, Union Bank, Zydus Lifesciences, Orient Cement ...